Skip to main navigation Skip to search Skip to main content

Bioengineered analog of stromal cell-derived factor 1α preserves the biaxial mechanical properties of native myocardium after infarction

  • Hanjay Wang
  • , Andrew Wisneski
  • , Michael J. Paulsen
  • , Annabel Imbrie-Moore
  • , Zhongjie Wang
  • , Yue Xuan
  • , Hector Lopez Hernandez
  • , Haley J. Lucian
  • , Anahita Eskandari
  • , Akshara D. Thakore
  • , Justin M. Farry
  • , Camille E. Hironaka
  • , Daniel von Bornstaedt
  • , Amanda N. Steele
  • , Lyndsay M. Stapleton
  • , Kiah M. Williams
  • , Matthew A. Wu
  • , John W. MacArthur
  • , Y. Joseph Woo

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Adverse remodeling of the left ventricle (LV) after myocardial infarction (MI) results in abnormal tissue biomechanics and impaired cardiac function, often leading to heart failure. We hypothesized that intramyocardial delivery of engineered stromal cell-derived factor 1α analog (ESA), our previously-developed supra-efficient pro-angiogenic chemokine, preserves biaxial LV mechanical properties after MI. Male Wistar rats (n = 45) underwent sham surgery (n = 15) or permanent left anterior descending coronary artery ligation. Rats sustaining MI were randomized for intramyocardial injections of either saline (100 μL, n = 15) or ESA (6 μg/kg, n = 15), delivered at four standardized borderzone sites. After 4 weeks, echocardiography was performed, and the hearts were explanted. Tensile testing of the anterolateral LV wall was performed using a displacement-controlled biaxial load frame, and modulus was determined after constitutive modeling. At 4 weeks post-MI, compared to saline controls, ESA-treated hearts had greater wall thickness (1.68 ± 0.05 mm vs 1.42 ± 0.08 mm, p = 0.008), smaller end-diastolic LV internal dimension (6.88 ± 0.29 mm vs 7.69 ± 0.22 mm, p = 0.044), and improved ejection fraction (62.8 ± 3.0% vs 49.4 ± 4.5%, p = 0.014). Histologic analysis revealed significantly reduced infarct size for ESA-treated hearts compared to saline controls (29.4 ± 2.9% vs 41.6 ± 3.1%, p = 0.021). Infarcted hearts treated with ESA exhibited decreased modulus compared to those treated with saline in both the circumferential (211.5 ± 6.9 kPa vs 264.3 ± 12.5 kPa, p = 0.001) and longitudinal axes (194.5 ± 6.5 kPa vs 258.1 ± 14.4 kPa, p < 0.001). In both principal directions, ESA-treated infarcted hearts possessed similar tissue compliance as sham non-infarcted hearts. Overall, intramyocardial ESA therapy improves post-MI ventricular remodeling and function, reduces infarct size, and preserves native LV biaxial mechanical properties.

Original languageEnglish
Pages (from-to)165-171
Number of pages7
JournalJournal of the Mechanical Behavior of Biomedical Materials
Volume96
DOIs
StatePublished - Aug 2019
Externally publishedYes

Keywords

  • Angiogenic therapy
  • Biaxial tension
  • Myocardial infarction
  • Ventricular remodeling

Fingerprint

Dive into the research topics of 'Bioengineered analog of stromal cell-derived factor 1α preserves the biaxial mechanical properties of native myocardium after infarction'. Together they form a unique fingerprint.

Cite this